PortfoliosLab logoPortfoliosLab logo
LLY vs. ML
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

LLY vs. ML - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Eli Lilly and Company (LLY) and MoneyLion Inc. (ML). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

Returns By Period


LLY

1D
-1.65%
1M
-4.63%
YTD
-12.44%
6M
13.07%
1Y
29.22%
3Y*
38.18%
5Y*
39.87%
10Y*
31.00%

ML

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

LLY vs. ML - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
LLY
Eli Lilly and Company
-12.44%40.25%33.30%60.91%34.26%66.08%13.07%
ML
MoneyLion Inc.
0.00%-0.13%37.20%237.04%-84.62%-64.34%15.31%

Correlation

The correlation between LLY and ML is -0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.06

Correlation (3Y)
Calculated over the trailing 3-year period

0.07

Correlation (5Y)
Calculated over the trailing 5-year period

0.06

Correlation (All Time)
Calculated using the full available price history since Aug 17, 2020

0.06

The correlation between LLY and ML shifts across timeframes, from -0.06 (1 year) to 0.07 (3 years), reflecting how their relationship changes across market environments.

Fundamentals

Total Revenue (TTM)

LLY:

$65.18B

ML:

$545.91M

Gross Profit (TTM)

LLY:

$54.62B

ML:

$409.26M

EBITDA (TTM)

LLY:

$27.94B

ML:

$56.96M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

LLY vs. ML — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LLY
LLY Risk / Return Rank: 5353
Overall Rank
LLY Sharpe Ratio Rank: 5656
Sharpe Ratio Rank
LLY Sortino Ratio Rank: 4949
Sortino Ratio Rank
LLY Omega Ratio Rank: 5252
Omega Ratio Rank
LLY Calmar Ratio Rank: 5353
Calmar Ratio Rank
LLY Martin Ratio Rank: 5555
Martin Ratio Rank

ML
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LLY vs. ML - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Eli Lilly and Company (LLY) and MoneyLion Inc. (ML). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


LLYMLDifference

Sharpe ratio

Return per unit of total volatility

0.76

Sortino ratio

Return per unit of downside risk

1.26

Omega ratio

Gain probability vs. loss probability

1.18

Calmar ratio

Return relative to maximum drawdown

1.00

Martin ratio

Return relative to average drawdown

2.43

LLY vs. ML - Sharpe Ratio Comparison


Loading graphics...

Sharpe Ratios by Period


LLYMLDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.76

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

1.24

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

1.04

Sharpe Ratio (All Time)

Calculated using the full available price history

0.56

Drawdowns

LLY vs. ML - Drawdown Comparison


Loading graphics...

Drawdown Indicators


LLYMLDifference

Max Drawdown

Largest peak-to-trough decline

-68.24%

Max Drawdown (1Y)

Largest decline over 1 year

-30.26%

Max Drawdown (5Y)

Largest decline over 5 years

-34.48%

Max Drawdown (10Y)

Largest decline over 10 years

-34.48%

Current Drawdown

Current decline from peak

-15.22%

Average Drawdown

Average peak-to-trough decline

-19.24%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.47%

Volatility

LLY vs. ML - Volatility Comparison


Loading graphics...

Volatility by Period


LLYMLDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.16%

Volatility (6M)

Calculated over the trailing 6-month period

24.99%

Volatility (1Y)

Calculated over the trailing 1-year period

41.85%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

32.20%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

29.83%

Dividends

LLY vs. ML - Dividend Comparison

LLY's dividend yield for the trailing twelve months is around 0.66%, while ML has not paid dividends to shareholders.


TTM20252024202320222021202020192018201720162015
LLY
Eli Lilly and Company
0.66%0.56%0.67%0.78%1.07%1.23%1.75%1.96%1.94%2.46%2.77%2.37%
ML
MoneyLion Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

LLY vs. ML - Financials Comparison

This section allows you to compare key financial metrics between Eli Lilly and Company and MoneyLion Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
19.29B
158.59M
(LLY) Total Revenue
(ML) Total Revenue
Values in USD except per share items